Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.

COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Abstract Text:

    katherine e burdickKatherine E Burdick,birgit funkeBirgit Funke,joseph f goldbergJoseph F Goldberg,john a batesJohn A Bates,judith jaegerJudith Jaeger,raju kucherlapatiRaju Kucherlapati,anil k malhotraAnil K Malhotra,

    OBJECTIVES: Bipolar disorder (BPD) is an affective disorder characterized by episodes of depression and mania. Cognitive impairment in patients with BPD is common and recent data suggest that it may represent a trait-like feature of the illness, as it persists during periods of wellness and co-segregates in families of bipolar patients. This suggests an underlying genetic predisposition towards cognitive impairment in patients with BPD; however, there have been few studies investigating the effects of candidate genes on this symptom domain. The catechol-O-methyl transferase (COMT) gene is located on chromosome 22q11 and is involved in the metabolism of dopamine and norepinephrine. A large body of evidence suggests that COMT is associated with cognitive performance in patients with schizophrenia and in healthy volunteers but there have been no reports of its relationship to cognition in BPD. METHODS: We genotyped 52 Caucasian bipolar I probands and 102 Caucasian healthy controls across four single nucleotide polymorphisms (SNPs) within the COMT gene and administered a cognitive screening battery. We first assessed the relationship between COMT genotype and diagnosis and then tested for effects on cognition. RESULTS: We observed a modest but significant association between SNP rs165599 and BPD I, with the g allele being over-represented in cases versus controls (odds ratio, OR = 2.41; allelic p = 0.02; genotypic p = 0.04). Further, we found a relationship between the risk allele at this SNP and poorer performance on measures of verbal memory [California Verbal Learning Test (CVLT) Trials 1-5; p = 0.005, eta(2) = 0.07] particularly with regard to prefrontal aspects of learning (CVLT semantic cluster; p = 0.037, eta(2) = 0.04) in patients with BPD and in healthy controls. The common Val158Met polymorphism was not associated with diagnosis (p = 0.32) or cognition in our sample. CONCLUSIONS: These data suggest that COMT genetic variation at SNP rs165599 is associated with BPD I and influences prefrontal aspects of verbal memory in bipolar patients and healthy controls.

    COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Publishing Authors By Initials

    ke burdickKE Burdick,b funkeB Funke,jf goldbergJF Goldberg,ja batesJA Bates,j jaegerJ Jaeger,r kucherlapatiR Kucherlapati,ak malhotraAK Malhotra,

    For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Bipolar disorders

    VOLUME: 9

    Page Numbers: 370-6

    Journal Abbreviation: Bipolar Disord

    ISSN: 1398-5647

    DAY: 3

    MONTH: Jun

    YEAR: 2007

    COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883596

    COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Keywords Mesh Terms:

    KEYWORDS: Risk Factors

    MESH TERMS: genetics

    Chemical & Substance for Abstract: COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Information

    Substance Name: Catechol O-Methyltransferase

    Registry Number: EC 2.1.1.6

    Grant and Affiliation Information for COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.

    AFFILIATION: Department of Psychiatry Research, Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA. kburdick@lij.edu

    Country: Denmark

    Denmark Research PublicationDenmark Research Publication

    AGENCY: United States NIMH

    GRANT: K23MH001760

    ACRONYM: MH

    MEDLINETA: Bipolar Disord

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News